The NMP22 test is relatively straightforward and non-invasive. A urine sample is collected from the patient and analyzed in a laboratory. The test measures the amount of NMP22 in the sample. Results are typically available within a few days. Elevated levels of NMP22 may prompt further diagnostic procedures, such as cystoscopy, to confirm the presence of bladder cancer.
